United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvas...
Leadership
Martine A. Rothblatt J.D., M.B.A., Ph.D.Founder
Founder, Chairman & CEO
Michael I. Benkowitz
President & COO
James C. Edgemond
CFO & Treasurer
Paul A. Mahon J.D.
Executive VP, General Counsel & Corporate Secretary
Harrison Silvers
Manager of Investor Relations
Holly Hobson
Associate Vice President of Human Resources
Leigh Peterson
Executive Vice President of Product Development & Xenotransplantation
